Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06327074 · ClinicalTrials.gov registry record · NA

Testing the Engaged Approach to Lung Cancer Screening

A NA study of Lung Cancer, sponsored by University of Colorado, Denver.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06327074 is a NA study of Lung Cancer that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 40 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06327074, a NA study of Lung Cancer, is active but no longer recruiting, sponsored by University of Colorado, Denver.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to assess feasibility and acceptability of the Engaged Approach to Lung Cancer Screening (EA-LCS) in diverse lung cancer screening (LCS) programs operating in a variety of geographic regions across Colorado and the US.

Conditions Studied

Interventions

  • BEHAVIORAL Engaged Approach to Lung Cancer Screening

Study Locations (1)

Colorado

  • University of Colorado Hospital - Denver

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-03-11
Est. Completion 2026-12
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT06327074

The ClinicalTrials.gov registry entry for NCT06327074 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (96% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Engaged Approach to Lung Cancer Screening is the first listed.

NCT06327074 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT06327074 about?

NCT06327074 is a clinical study titled "Testing the Engaged Approach to Lung Cancer Screening". The goal of this study is to assess feasibility and acceptability of the Engaged Approach to Lung Cancer Screening (EA-LCS) in diverse lung cancer screening (LCS) programs operating in a variety of geographic regions across Colorado and the US.

What is the current status of trial NCT06327074?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-03-11. Estimated completion is 2026-12.

What conditions does trial NCT06327074 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT06327074?

The interventions under investigation include: Engaged Approach to Lung Cancer Screening (BEHAVIORAL).

Who is sponsoring clinical trial NCT06327074?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06327074 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.